Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor
about
Spontaneous mutations in the env gene of the human immunodeficiency virus type 1 NDK isolate are associated with a CD4-independent entry phenotype.A putative G protein-coupled receptor, RDC1, is a novel coreceptor for human and simian immunodeficiency virusesHuman immunodeficiency virus type 1 envelope glycoprotein gp120 produces immune defects in CD4+ T lymphocytes by inhibiting interleukin 2 mRNACD4-binding regions of human immunodeficiency virus envelope glycoprotein gp120 defined by proteolytic digestionRecombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitroPathogenesis of human immunodeficiency virus infectionGlycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 bindingT helper cell activation and human retroviral pathogenesisCharacterization of a human homologue of the murine peripheral lymph node homing receptorHTLV-1/-2 and HIV-1 co-infections: retroviral interference on host immune statusMultiscale perspectives of virus entry via endocytosisVaccinia virus L1 binds to cell surfaces and blocks virus entry independently of glycosaminoglycansKinetic and structural analysis of mutant CD4 receptors that are defective in HIV gp120 bindingInhibition of human immunodeficiency virus (HIV) infection in vitro by anticarbohydrate monoclonal antibodies: peripheral glycosylation of HIV envelope glycoprotein gp120 may be a target for virus neutralizationAnti-human immunodeficiency virus type 1 activity of an oligocationic compound mediated via gp120 V3 interactionsA synthetic all D-amino acid peptide corresponding to the N-terminal sequence of HIV-1 gp41 recognizes the wild-type fusion peptide in the membrane and inhibits HIV-1 envelope glycoprotein-mediated cell fusionCharacterization of neutralizing monoclonal antibodies to linear and conformation-dependent epitopes within the first and second variable domains of human immunodeficiency virus type 1 gp120Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoproteinModelling of poliovirus. HIV-1 antigen chimaeras.Direct evidence for native CD4 oligomers in lymphoid and monocytoid cells.Processing, stability, and receptor binding properties of oligomeric envelope glycoprotein from a primary HIV-1 isolate.Properties and structures of the influenza and HIV fusion peptides on lipid membranes: implications for a role in fusionCD4 and its role in infection of rabbit cell lines by human immunodeficiency virus type 1Matrix-assisted laser desorption ionization/mass spectrometry mapping of human immunodeficiency virus-gp120 epitopes recognized by a limited polyclonal antibody.Leukocyte-specific protein 1 interacts with DC-SIGN and mediates transport of HIV to the proteasome in dendritic cells.Internal-image anti-idiotype HIV-1gp120 antibody in human immunodeficiency virus 1 (HIV-1)-seropositive individuals with thrombocytopeniaMolecular characterization of biologically diverse envelope variants of human immunodeficiency virus type 1 derived from an individual.Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.A soluble recombinant polypeptide comprising the amino-terminal half of the extracellular region of the CD4 molecule contains an active binding site for human immunodeficiency virus.Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120The N-terminal region of the human immunodeficiency virus envelope glycoprotein gp120 contains potential binding sites for CD4.Class II MHC molecules and the HIV gp 120 envelope protein interact with functionally distinct regions of the CD4 moleculeProtease cleavage sites in HIV-1 gp120 recognized by antigen processing enzymes are conserved and located at receptor binding sitesHuman immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gp120Genetic variability between isolates of human immunodeficiency virus (HIV) type 2 is comparable to the variability among HIV type 1.Binding site for human immunodeficiency virus coat protein gp120 is located in the NH2-terminal region of T4 (CD4) and requires the intact variable-region-like domain.Production and characterization of a soluble, active form of Tva, the subgroup A avian sarcoma and leukosis virus receptor95- and 25-kDa fragments of the human immunodeficiency virus envelope glycoprotein gp120 bind to the CD4 receptorFailure of a human immunodeficiency virus (HIV) immune globulin to protect chimpanzees against experimental challenge with HIV.Induction of anti-human immunodeficiency virus (HIV) neutralizing antibodies in rabbits immunized with recombinant HIV--hepatitis B surface antigen particles.
P2860
Q24523003-0081D13C-407E-4570-9AFA-2A3C51697FDCQ24524308-D4DAF249-0744-4653-A3B7-598B451621F6Q24558732-019AF06C-B9CD-4CEF-9CD6-88132ABA92E2Q24559959-39623CAE-89F4-480E-A325-DD3D5A7E5893Q24563642-8DF5BCCB-292D-4341-8606-04E151672681Q24634681-2CF28470-7524-4C2B-82A9-E139DB31F7C9Q24644617-55575028-195A-4852-9C52-5A21A222731DQ24650854-B766822E-8756-4200-BC08-86616F7445C2Q24679585-80057446-96E4-4AD0-B9DD-586F41E4B411Q26866444-85CE4543-928E-457C-AB5F-67E191DDE469Q27026314-88750605-A7A1-45BE-B22D-70D75FC2799BQ27488704-5C234ED5-4CFD-4CF2-9074-9C38E36E264CQ27734294-A67F637C-A157-495A-A325-30BCEA0E17ACQ28323332-34078478-0449-489E-86E2-BA863B037105Q28378840-75A338FC-4F03-426A-8D47-1274D51C1167Q28379574-44B9068B-7D9E-4287-8278-E164A5042CAAQ28646835-A06A2E47-0321-42B1-8BC5-CA62195B13B1Q28646850-87C36960-4CB9-46A0-A5E0-8A6D7B66A0E1Q30195803-82B529E1-B972-4021-890A-D7C641CB16F7Q30757946-EAE52F8E-2DD7-465C-A306-DD2A19D0FD28Q30894431-BFCE0645-BDDE-404D-AFA8-337873D44CDDQ31007193-8B1B5D16-A37A-4778-90A6-990D26FB6C56Q31076336-6D5477E8-4DC8-48C9-A1DC-0B5EC0DCEC9CQ32049913-318E2957-2A94-45DB-B653-B5C544930A56Q33273505-CD71FD56-6456-468A-B9F0-549539116560Q33374816-8E8C9F9A-2561-4C23-84F2-7381BA83B0C6Q33379671-AA101C7E-5DF0-48BF-B13C-EC7329C9F1E5Q33560772-DD9ACC3D-A819-423E-A5A4-54AC6FF6EDDBQ33564946-3F096DA0-5C9E-43C2-B8E2-6A4CB9AD7463Q33571605-09240765-070B-4EB8-8744-EE8A349401ADQ33579510-8AF39BCE-9F5D-4D2C-8478-34361FE30FFAQ33584112-FC0E106A-0788-44E9-A996-022A18D1F2E5Q33614461-15B60D80-D328-4C50-BCB2-1EFF801CFA13Q33632668-DB41A273-D436-48AC-8DD8-301AEB9ADA26Q33639547-0E0F3CE7-E541-4C5D-88E3-99945161AF99Q33641132-CD8E611C-60AA-48EA-A7AC-4D8DF29EC1A3Q33644217-386F282C-C6AE-43A9-855A-67D2FD698B1DQ33645518-28912A07-4CCD-4DCD-9C78-4F22B237F5CDQ33649062-65307C92-40E6-4812-A866-DA953046F2DFQ33660809-E0EDACB6-E9B9-4387-9AF7-39F1A4B08694
P2860
Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor
description
1987 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1987
@ast
im September 1987 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1987/09/11)
@sk
vědecký článek publikovaný v roce 1987
@cs
wetenschappelijk artikel (gepubliceerd op 1987/09/11)
@nl
наукова стаття, опублікована у вересні 1987
@uk
مقالة علمية (نشرت في 11-9-1987)
@ar
name
Delineation of a region of the ...... eraction with the CD4 receptor
@ast
Delineation of a region of the ...... eraction with the CD4 receptor
@en
Delineation of a region of the ...... eraction with the CD4 receptor
@nl
type
label
Delineation of a region of the ...... eraction with the CD4 receptor
@ast
Delineation of a region of the ...... eraction with the CD4 receptor
@en
Delineation of a region of the ...... eraction with the CD4 receptor
@nl
prefLabel
Delineation of a region of the ...... eraction with the CD4 receptor
@ast
Delineation of a region of the ...... eraction with the CD4 receptor
@en
Delineation of a region of the ...... eraction with the CD4 receptor
@nl
P2093
P1433
P1476
Delineation of a region of the ...... eraction with the CD4 receptor
@en
P2093
C. Shimasaki
D. H. Smith
D. J. Capon
G. Nakamura
L. A. Lasky
T. Gregory
P304
P356
10.1016/0092-8674(87)90524-1
P407
P577
1987-09-11T00:00:00Z